IGF2BP3 and neoplasm: In particular, the results of this and other studies43–46 showed that IGF2BP3 also stimulated the progression of KIRC and that IGF2BP3 levels in tumor tissues, and peripheral blood could be used as a predictor of KIRC metastasis and clinical prognosis.